These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 9190845

  • 1. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release.
    Golenser J, Domb A, Teomim D, Tsafack A, Nisim O, Ponka P, Eling W, Cabantchik ZI.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1127-35. PubMed ID: 9190845
    [Abstract] [Full Text] [Related]

  • 2. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J, Domb A, Mordechai-Daniel T, Leshem B, Luty A, Kremsner P.
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [Abstract] [Full Text] [Related]

  • 3. Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria.
    Postma NS, Hermsen CC, Zuidema J, Eling WM.
    Exp Parasitol; 1998 Jul; 89(3):323-30. PubMed ID: 9676710
    [Abstract] [Full Text] [Related]

  • 4. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A, Golenser J, Libman J, Shanzer A, Cabantchik ZI.
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [Abstract] [Full Text] [Related]

  • 5. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 6. [Iron chelation in antimalarial therapy].
    Pradines B, Millet J, Henry M.
    Med Trop (Mars); 2003 Jan; 63(2):119-30. PubMed ID: 12910648
    [Abstract] [Full Text] [Related]

  • 7. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK, Kalinowski DS, Richardson DR.
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [Abstract] [Full Text] [Related]

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 9. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
    Ishih A, Suzuki T, Muregi FW, Matsui K, Terada M.
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
    [Abstract] [Full Text] [Related]

  • 10. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T, Gustafsson B, Brunk UT.
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [Abstract] [Full Text] [Related]

  • 11. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF, de Abreu Vieira PM, Arantes JM, Pedrosa ML, Martins HR, Silva M, Veloso VM, de Lana M, Bahia MT, Tafuri WL, Carneiro CM.
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [Abstract] [Full Text] [Related]

  • 12. Antimalarial effect of agmatine on Plasmodium berghei K173 strain.
    Su RB, Wei XL, Liu Y, Li J.
    Acta Pharmacol Sin; 2003 Sep; 24(9):918-22. PubMed ID: 12956942
    [Abstract] [Full Text] [Related]

  • 13. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A, Miyase T, Ohori K, Terada M.
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [Abstract] [Full Text] [Related]

  • 14. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
    Sterba M, Popelová O, Simůnek T, Mazurová Y, Potácová A, Adamcová M, Guncová I, Kaiserová H, Palicka V, Ponka P, Gersl V.
    Toxicology; 2007 Jun 25; 235(3):150-66. PubMed ID: 17459556
    [Abstract] [Full Text] [Related]

  • 15. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA, Ruenruetai U, Noor Rain A, Khozirah S, Zakiah I.
    Trop Biomed; 2006 Dec 25; 23(2):140-6. PubMed ID: 17322815
    [Abstract] [Full Text] [Related]

  • 16. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
    Pattanapanyasat K, Kotipun K, Yongvanitchit K, Hider RC, Kyle DE, Heppner DG, Walsh DS.
    Southeast Asian J Trop Med Public Health; 2001 Mar 25; 32(1):64-9. PubMed ID: 11485097
    [Abstract] [Full Text] [Related]

  • 17. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS, Crommelin DJ, Eling WM, Zuidema J.
    J Pharmacol Exp Ther; 1999 Jan 25; 288(1):114-20. PubMed ID: 9862761
    [Abstract] [Full Text] [Related]

  • 18. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
    Shu-Hua X, Utzinger J, Chollet J, Tanner M.
    Int J Parasitol; 2006 Jul 25; 36(8):957-64. PubMed ID: 16750833
    [Abstract] [Full Text] [Related]

  • 19. Retinol supplementation in murine Plasmodium berghei malaria: effects on tissue levels, parasitaemia and lipid peroxidation.
    Hamzah J, Batty KT, Davis WA, Mori TA, Ching SY, Croft KD, Davis TM.
    Int J Parasitol; 2007 Apr 25; 37(5):525-37. PubMed ID: 17157853
    [Abstract] [Full Text] [Related]

  • 20. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N, Buss JL, Soe-Lin S, Felfly H, Trudel M, Ponka P.
    Exp Hematol; 2008 Jul 25; 36(7):773-85. PubMed ID: 18456387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.